Abstract
Recurrent episodes of hepatic encephalopathy (HE) frequently occur in surgically shunted cirrhotic patients. The prevention of these episodes is based mainly on the long-term use of lactulose. Recently, lactitol, a nonabsorbable disaccharide similar to lactulose, has been proposed as an alternative in the management of HE. It has the advantage of being better tolerated and producing a more predictable catharsis. The effects of the two agents were compared in a controlled randomized study lasting six months involving 31 cirrhotic patients with portal-systemic shunt, of whom 40% experienced HE. The PSE index (mental state, EEG, asterixis, Raitan test, and ammonia) was assessed in each patient on entry to the study and every three months during treatment. Episodes of HE, side effects, and the patients' comments on efficacy, tolerability, and palatability were recorded. The dose required to induce two bowel movements per day was 48± 25 ml of lactulose syrup and 36±7 g of lactitol. During the study, the number of patients who had an episode of HE and the PSE index was similar in both groups. The patients judged lactitol better from the point of view of palatability. Meteorism and flatulence, experienced by patients treated with lactulose, was not reported by the lactitol group. We concluded that lactitol is as effective as lactulose in the long-term prevention of episodes of HE in cirrhotics with portal-systemic shunt and may be better tolerated.
Similar content being viewed by others
References
Sherlock S, Summerskill WJH, White LP, Phear EA: Portal systemic encephalopathy. Neurological complications of liver disease. Lancet 2:453–457, 1954
Mutchnick MG, Lerher E, Conn HO: Portal-systemic encephalopathy and portal anastomosis: A prospective, controlled investigation. Gastroenterology 66:1005–1019, 1974
Conn HO, Lieberthal MM: the Hepatic Coma Syndromes and Lactulose. Baltimore, Williams & Wilkins, 1979
Kaupke C, Sprague T, Gitnick GL: Hypernatriemia after the administration of lactulose. Ann Intern Med 86:745–746, 1977
Patil DH, Grimble GK, Silk DBA: Intestinal absorption and laxative threshold of lactitol—a new hydrogenated derivative of lactose. Gut 26:A1114, 1985(abstract)
Bircher J, Buhrer M, Franz K, Velthuijsen JA: First use of lactitol in the treatment of portal-systemic encephalopathy. Schweiz Med Wochenschr 112:1306–1307, 1982
Lanthier PL, Morgan MY: Lactitol in the treatment of chronic hepatic encephalopathy: An open comparison with lactulose. Gut 26:415–420, 1985
Morgan MY, Hawley KE, Stambuk D: Lactitol versus lactulose in the treatment of chronic hepatic encephalopathy. A double-blind, randomized, cross-over study. J Hepatol 4:236–244, 1987
Hawley KE, Morgan MY: Lactitol versus lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: A double-blind randomised trial. Hepatology 6:1149, 1986 (abstract)
Conn HO: The trailmaking and number connection tests in the assessment of mental state in portal systemic encephalopathy. Am J Dig Dis 22:541–550, 1977
Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, Seef L, Levy LL: Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. Gastroenterology 72:573–583, 1977
Merli M, Riggio O, Iapichino S, Capocaccia L: Amino acid imbalance and malnutrition in liver cirrhosis. Clin Nutr 4:249–253, 1985
Denkla WD, Dewey HK: The determination of tryptophan in plasma, liver and urine. J Lab Med 69:160–166, 1967
Bloxam DL, Warren WH: Error in the determination of tryptophan by method of Denkle and Dewey. A revised procedure. Anal Biochem 60:621–625, 1974
Bloxam DL, Hutson PH, Curzon G: A simple apparatus for ultrafiltration of small volumes. Application to the measurement of free and albumine-bound tryptophan in plasma. Anal Biochem 83:130–142, 1977
Hoyumpa AM, Desmond PV, Avant GR, Roberts RK, Shenker S: Hepatic encephalopathy. Gastroenterology 76:184–195, 1979
Conn HO; Lactulose: A drug in search of a modus operandi. Gastroenterology 74:624–626, 1978
Vince A, Kllingley M, Wrong OM: Effect of lactulose on ammonia production in a fecal incubation system. Gastroenterology 74:544–549, 1978
Liehr H, Englisch G, Rasenaek V: Lactulose—a drug with antiendotoxin effect. Hepatogastroenterology 27:356–360, 1980
Patil DH, Westaby DH, Mahida YR, Palmer RK, Rees R, Clark HL, Dawson AM, Silk DBA: Comparative modes of action of lactitol and lactulose in the treatment of hepatic encephalopathy. Gut 28:255–259, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Riggio, O., Balducci, G., Ariosto, F. et al. Lactitol in prevention of recurrent episodes of hepatic encephalopathy in cirrhotic patients with portal-systemic shunt. Digest Dis Sci 34, 823–829 (1989). https://doi.org/10.1007/BF01540265
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01540265